CG:603998 Hunan Fangsheng Pharmaceutical Co., Ltd

Hunan Fangsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company offers cardio-cerebrovascular, pediatric, gynecological, orthopedics, traumatology, anti-infective, oncology, digestive system, urinary system, heat-clearing and detoxifying, and other drugs. It is also involved in the wholesale of pharmaceutical products and medical devices; provision of biotechnology related research, consulting, technical transfer, and other technology based services; and research and industrialization of individualized medicine laboratory technology. The company was founded in 2002 and is based in Changsha, China.

5.64 CNY
As of 01/28/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Unknown
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  12/05/2014
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   2,460,634,112 CNY
Current dividend yield:   2.87%
Sedol:      

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy